Skip to main content
TipRanks
Go Ultimate75% OFF

Vivoryon Therapeutics AG (0R3M) Ownership - Who Owns Vivoryon Therapeutics AG?

2 Followers

Vivoryon Therapeutics AG (0R3M) Ownership Overview

  • 1.04% Insiders
  • 98.96% Public Companies and Individual Investors

The ownership structure of Vivoryon Therapeutics AG (GB:0R3M) stock is a mix of institutional, retail, and individual investors. , 1.04% is owned by Insiders, and 98.96% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Dec 14, 2025Frank Weber€55,386
Dec 09, 2025Erich Platzer€233,144

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

GB:0R3M top shareholders
Holder# of SharesType% HoldingValue
Frank Weber179,550Insider0.61%143,999
Erich Platzer128,809Insider0.43%103,305

FAQ

What percentage of Vivoryon Therapeutics AG (GB:0R3M) stock is held by retail investors?
According to the latest TipRanks data, approximately 98.96% of Vivoryon Therapeutics AG (GB:0R3M) stock is held by public companies and individual investors.
Who owns the most shares of Vivoryon Therapeutics AG (GB:0R3M)?
Frank Weber owns the most shares of Vivoryon Therapeutics AG (GB:0R3M).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.